Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Cell · 2023-08 · 186 (16) · 3476-3498.e35
DOI: 10.1016/j.cell.2023.07.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-08. Verfasst von Shrabanti Chowdhury und 46 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Cystadenocarcinoma, Serous, Ovarian Neoplasms, Proteogenomics. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Department of Computational Medicine and Bioinformatics, Michigan Center for Translational Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.
- Tisch Cancer Institute, Department of Population Health Science and Policy, Institute for Health Care Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
- Syapse, Inc., San Francisco, CA 94115, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- AstraZeneca
- National Institutes of Health Office of the Director
- Office of Research Infrastructure Programs, National Institutes of Health
- Clovis Oncology
- Aventis Foundation
- U.S. Department of Defense
Zitieren
APA
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A., Savage, S. R., Berry, A. B., Reva, B., Ozbek, U., Krek, A., Ma, W., da Veiga Leprevost, F., Ji, J., Yoo, S., Lin, C., Voytovich, U. J., …, & Paulovich, A. G. (2023). Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell, 186(16), 3476-3498.e35. https://doi.org/10.1016/j.cell.2023.07.004
Vancouver
Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2023;186(16):3476-3498.e35. doi:10.1016/j.cell.2023.07.004
BibTeX
@article{Chowdhury2023,
author = {Chowdhury, Shrabanti and Kennedy, Jacob J and Ivey, Richard G and Murillo, Oscar D and Hosseini, Noshad and Song, Xiaoyu and Petralia, Francesca and Calinawan, Anna and Savage, Sara R and Berry, Anna B and Reva, Boris and Ozbek, Umut and Krek, Azra and Ma, Weiping and da Veiga Leprevost, Felipe and Ji, Jiayi and Yoo, Seungyeul and Lin, Chenwei and Voytovich, Uliana J and Huang, Yajue and Lee, Sun-Hee and Bergan, Lindsay and Lorentzen, Travis D and Mesri, Mehdi and Rodriguez, Henry and Hoofnagle, Andrew N and Herbert, Zachary T and Nesvizhskii, Alexey I and Zhang, Bing and Whiteaker, Jeffrey R and Fenyo, David and McKerrow, Wilson and Wang, Joshua and Schürer, Stephan C and Stathias, Vasileios and Chen, X Steven and Barcellos-Hoff, Mary Helen and Starr, Timothy K and Winterhoff, Boris J and Nelson, Andrew C and Mok, Samuel C and Kaufmann, Scott H and Drescher, Charles and Cieslik, Marcin and Wang, Pei and Birrer, Michael J and Paulovich, Amanda G},
title = {Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer},
journal = {Cell},
year = {2023},
volume = {186},
number = {16},
pages = {3476--3498.e35},
doi = {10.1016/j.cell.2023.07.004}
}
EUVIMED